Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Bhutan

Bhutan

The Other Vaccines market in Bhutan is expected to achieve a revenue of US$294.70k in the year 2024.
It is projected to experience a steady annual growth rate (CAGR 2024-2029) of 10.18%.
This growth is anticipated to lead to a market volume of US$478.60k by the year 2029.
When compared globally, United States is expected to generate the highest revenue, amounting to US$24,730.00m in the year 2024.
Bhutan's growing focus on public health and preventive measures has led to an increased demand for other vaccines in the country.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

Bhutan, a small country nestled in the Eastern Himalayas, has been making strides in its healthcare sector in recent years. The Other Vaccines market in Bhutan has been developing at a steady pace, with increasing demand for vaccines to prevent diseases such as meningitis, pneumonia, and hepatitis B.

Customer preferences: Bhutan has a small population with a high demand for healthcare services. The government of Bhutan provides free healthcare to its citizens, and this has led to an increase in demand for vaccines. The majority of the population lives in rural areas, and there is a strong preference for vaccines that are easy to administer and require fewer doses.

Trends in the market: The Other Vaccines market in Bhutan has been growing steadily due to an increase in government funding for healthcare services. There has been a growing trend towards the use of combination vaccines, which offer protection against multiple diseases in a single shot. This has led to an increase in demand for vaccines such as Pentavalent and Hexavalent vaccines.

Local special circumstances: One of the unique challenges in Bhutan is the difficult terrain, which makes it difficult to transport vaccines to remote areas. To overcome this challenge, the government has implemented a cold chain system to ensure that vaccines are stored and transported at the correct temperature. Additionally, the government has introduced mobile vaccination teams to reach remote areas.

Underlying macroeconomic factors: Bhutan has a small economy, and the healthcare sector is heavily dependent on government funding. The government has been investing heavily in the healthcare sector, and this has led to an increase in demand for vaccines. Additionally, Bhutan has a young population, and this has led to an increase in demand for pediatric vaccines. The government has also been working to increase awareness about the importance of vaccination, and this has led to an increase in demand for vaccines among the general population.In conclusion, the Other Vaccines market in Bhutan has been developing at a steady pace, driven by an increase in government funding for healthcare services and a growing awareness about the importance of vaccination. The use of combination vaccines and the implementation of a cold chain system have helped to overcome the unique challenges posed by the difficult terrain. The government's continued investment in the healthcare sector is expected to drive further growth in the Other Vaccines market in Bhutan.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.